XML 81 R32.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
STOCKHOLDERS' EQUITY  
Schedule of share-based compensation

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2025

    

2024

    

2025

    

2024

Stock options

​

$

2,083,722

​

$

97,655

​

$

2,487,805

​

$

161,124

RSUs

​

 

1,772,753

​

 

55,064

​

 

2,200,967

​

 

292,442

Total share-based compensation expense

​

$

3,856,475

​

$

152,719

​

$

4,688,772

​

$

453,566

Schedule of aggregate non-cash stock-based compensation recognized

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2025

    

2024

    

2025

    

2024

General and administrative

​

$

145,828

​

$

67,708

​

$

476,921

​

$

295,485

Salaries and benefits

​

 

3,706,746

​

 

82,410

​

 

4,200,149

​

 

155,480

Professional fees

​

 

3,901

​

 

2,601

​

 

11,702

​

 

2,601

Total non-cash share-based compensation expense

​

$

3,856,475

​

$

152,719

​

$

4,688,772

​

$

453,566

Schedule of stock options

​

​

​

​

​

​

​

    

Nine Months

 

​

​

Ended

 

​

​

September

 

Weighted-Average Grant Date Assumptions

​

30, 2025

 

Expected term (in years)

 

​

9.3

​

Risk-free interest rate

 

​

4.3

%

Expected dividend yield

 

​

0.0

%

Expected volatility

 

​

96.0

%

Fair value per share

​

$

2.49

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

Weighted-

​

​

​

​

​

​

​

Average

​

Average

​

​

​

​

​

​

​

Exercise

​

Remaining

​

Aggregate

​

​

​

​

Price Per

​

Contractual

​

Intrinsic

​

    

Shares

    

Share

    

Term (in years)

    

Value

Options outstanding, December 31, 2024

 

4,330,000

​

$

0.23

 

3.7

​

$

6,652,700

Granted

 

2,391,400

​

 

2.41

 

—

​

 

—

Exercised

 

(672,500)

​

 

0.23

 

—

​

 

—

Forfeited

 

(166,667)

​

 

0.22

 

—

​

 

—

Expired

 

—

​

 

—

 

—

​

 

—

Options outstanding, September 30, 2025

 

5,882,233

​

$

1.12

 

5.7

​

$

29,818,109

Nonvested options, September 30, 2025

 

5,190,566

​

$

1.21

 

5.8

​

$

25,801,817

Vested and exercisable options, September 30, 2025

 

691,667

​

$

0.39

 

4.4

​

$

4,016,292

Schedule of restricted stock units

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

Average

​

​

​

​

Grant Date

​

​

​

​

Fair Value

​

    

Shares

    

Per Share

RSUs outstanding at December 31, 2024

 

2,090,000

​

$

0.24

Granted

 

2,182,800

​

 

2.86

Vested

 

(1,428,199)

​

 

1.16

Forfeited

 

—

​

 

—

RSUs outstanding at September 30, 2025

 

2,844,601

​

$

1.79

Schedule of common stock warrants

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

Number of

​

Average

​

    

Warrants

    

Exercise Price

Balance at December 31, 2024

 

10,142,215

​

$

0.77

Exercised

 

(5,772,822)

​

 

0.77

Balance at September 30, 2025

 

4,369,393

​

$

0.77

Schedule of warrants outstanding

​

​

​

​

​

​

​

​

​

Number of warrants

    

Exercise Price

    

Expiration Date

    

Remaining life (years)

857,143

​

$

0.46

 

1/27/2026

 

0.33

806,500

​

$

0.85

 

2/1/2026

 

0.34

2,705,750

​

$

0.85

 

8/3/2026

 

0.84

4,369,393

​